Divisadero Street Capital Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,315,913
Closed -$13.2M 85
2024
Q2
$13.2M Sell
1,315,913
-256,987
-16% -$2.82M 2% 14
2024
Q1
$19.1M Buy
1,572,900
+623,350
+66% +$9.04M 4.47% 9
2023
Q4
$13.6M Buy
+949,550
New +$9.11M 3.07% 12

Other funds holding OPRX

Divisadero Street Capital Management's OPRX Position: Q3 2024 in Review

Divisadero Street Capital Management sold out of OptimizeRx (OPRX) in Q3 2024, closing a stake of 1,315,913 shares — an estimated $13.2M sold.

Divisadero Street Capital Management first reported a position in OPRX in Q4 2023 and held it in 3 quarters. The position peaked at $19.1M in Q1 2024. 85 funds tracked by Wall St. Rank hold OPRX as of Q3 2024.

  • Divisadero Street Capital Management reported no remaining OptimizeRx position as of Q3 2024 after selling out during the quarter.
  • Divisadero Street Capital Management sold 1,315,913 OptimizeRx shares in Q3 2024, an estimated $13.2M.
  • Divisadero Street Capital Management first reported a position in OptimizeRx in Q4 2023 and held it in 3 quarters.
  • Divisadero Street Capital Management's OptimizeRx position peaked at $19.1M in Q1 2024.
  • 85 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2024.

Based on Divisadero Street Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.